Tirzepatide emerges a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://nannieuxwf580742.arwebo.com/63019626/tirzepatide-a-game-changer-for-type-2-diabetes